Articles tagged "Outcome"

2015 American Transplant Congress
Epidemiology and Outcomes of Non Tuberculous Mycobacterial (NTM) Infections in Solid Organ Transplant (SOT) Recipients
I. George, C. Santos, M. Olsen, T. Bailey.
Infectious Diseases, Washington University School of Medicine, St. Louis, MO.
Background: NTM are uncommon causes of infection in SOT recipients but may cause significant morbidity and mortality.Methods: A retrospective cohort of all patients who underwent…
2015 American Transplant Congress
Implications of Living Donor Kidney Histology, Volume and Function on Post-Donation GFR
Z. Zaky,¹ B. Lankowsky,² S. Shah,¹ L. Herlitz,¹ A. Chiesa-Vottero,¹ K. Wallenfelsz,¹ A. Caplin,¹ D. Goldfarb,¹ S. Flechner,¹ J. Schold,¹ E. Poggio.¹
¹Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH; ²CWRU School of Medicine, Cleveland, OH.
Living kidney donor transplantation is the best modality for treating ESRD as it confers excellent outcomes to patients and it is safe for donors. Postdonation…
2015 American Transplant Congress
Utilization of Increased Risk Donors in a Canadian Multi-Organ Transplant Program
K. Doucette,¹ K. Worton,² J. Kutsogiannis,² J. Preiksaitis.¹
¹Department of Medicine, University of Alberta, Edmonton, AB, Canada; ²Human Organ Procurement Exchange (HOPE) Program, Alberta Health Services, Edmonton, AB, Canada.
Background: Due to a shortage of organ donors and increasing mortality on the wait list, marginal donors, including those at increased risk for blood borne…
2015 American Transplant Congress
Safety and Efficacy of Early Everolimus in De Novo Orthotopic Liver Transplantation
M. Gastaca,¹ I. Bilbao,² M. Jimenez,³ J. Bustamente,¹ C. Dopazo,² R. Gonzalez,³ R. Charco,² J. Santoyo,⁴ J. Ortiz de Urbina.¹
¹Liver Transplantation Unit, Cruces University Hospital. University of the Basque Country, Bilbao, Vizcaya, Spain; ²Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitario Vall d´Hebron, Barcelona, Spain; ³Unidad de Hepatología-Trasplante Hepático, Hospital Regional Universitario de Malaga, Malaga, Spain; ⁴Unidad de Cirugía Hepatobiliar-Trasplante Hepático, Hospital Regional Universitario de Malaga, Malaga, Spain.
Purpose: To study the safety and efficacy of immunosuppression with Everolimus (EVL) within the first month after orthotopic liver transplantation.Patients and methods: Recipients who had…
2015 American Transplant Congress
Systematic Medical Record Review to Identify Safety Risks in Living Liver Donors
B. Platt,⁵ D. Woods,⁵ R. Fisher,² J. Guarrera,³ E. Pomfret,⁴ M. Simpson,⁴ A. Daud,¹ T. Curtis,⁵ E. Reyes,⁵ E. Wymore,⁵ A. Skaro,¹ D. Ladner.¹
¹Northwestern University, Chicago, IL; ²Virginia Commonwealth University, Richmond, VA; ³Columbia University, New York, NY; ⁴Lahey Clinic, Boston, MA; ⁵CHS, Northwestern University, Chicago, IL.
BACKGROUNDPrevention of adverse events (AEs) is important in Living Donor Liver Transplantation (LDLT), as these are healthy volunteers who undergo a major procedure with no…
2015 American Transplant Congress
The Penalty Faced By Native Americans in Kidney Transplantation: Decreased Access and Reduced Long-Term Survival
S. Stith,¹ F. Barrantes,² K. Piorkowski.¹
¹Department of Economics, University of New Mexico, Albuquerque, NM; ²Renal Medicine Associates/Presbyterian Transplant Center, Albuquerque, NM.
Background: Diabetes and ESRD disproportionately affect NAs (Native Americans), yet waitlisted NAs have lower rates of kidney transplantation than other racial/ethnic groups and worse longer…
2015 American Transplant Congress
Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval
Y. Nobel,¹ D. Goldberg.^2,3,4
¹Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ²Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA; ³Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ⁴Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA.
Purpose: Most patients with metastatic neuroendocrine tumors (NETs) have preserved hepatic synthetic function, and their providers may seek increased waitlist priority via MELD exception points.…
2015 American Transplant Congress
Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation
E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 D. Segev.^1,2
¹Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD; ²Epidemiology, Johns Hopkins University, School of Public Health, Baltimore, MD.
Background: Early hospital readmission (EHR) is associated with increased morbidity and mortality after kidney transplantation. However, following simultaneous pancreas-kidney transplantation (SPK), EHR rates are unknown,…
2015 American Transplant Congress
Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients
X.-Z. Wang, W.-J. Xue, X.-H. Tian, J. Zheng, P.-X. Tian, X.-M. Ding.
Kidney Transplantation, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Objective To explore the significance of serum CD30 in predicting acute rejection and pneumonia in kidney transplant recipients. Methods A total of 106 kidney transplant…
2015 American Transplant Congress
Controlled DCD Pancreas Transplantation : A Single Centre Experience
M. Voskuil, S. Mittal, A. Muthusamy, J. Gilbert, S. Sinha, I. Quiroga, S. Reddy, P. Friend, E. Sharples, A. Vaidya, R. Ploeg.
Oxford Transplant Centre, Oxford University, Oxford, United Kingdom.
Background: The use of DCD pancreata are gaining popularity in the UK. Isolated pancreas transplantation (IP) is known to have inferior outcomes in comparison to…